Exploring the ethics and global governance of genome editing

Thanks to significant technological advances, genome editing is becoming increasingly accessible. The healthcare applications of such innovations offer great potential for personalized medicine and the understanding of many diseases. However, genome-editing techniques also carry safety risks and raise ethical questions. While the potential benefits of genetic therapies on somatic cells could be significant, related scientific practices remain largely unsupervised and access to these therapies is limited. On the other hand, the hereditary modifications enabled by genome editing of embryos are widely decried as unethical. Leading institutions have established governance frameworks to define the parameters for the ethical use of this technology, while working with regulators to apply relevant norms and standards. In a complex international environment, how can we bring this issue to the fore at the political level, so as to define the limits to the use of this biotechnology, while at the same time allowing us to benefit from its potential advantages? Follow us on social media • 𝗧𝘄𝗶𝘁𝘁𝗲𝗿 - • 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻 - • 𝗙𝗮𝗰𝗲𝗯𝗼𝗼𝗸 - • 𝗜𝗻𝘀𝘁𝗮𝗴𝗿𝗮𝗺 - • 𝗧𝗶𝗸𝗧𝗼𝗸 - @parispeaceforum_